Apollo Hospitals Enterprise (NSE:APOLLOHOSP) COGS-to-Revenue : 0.52 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Apollo Hospitals Enterprise COGS-to-Revenue?

Apollo Hospitals Enterprise's Cost of Goods Sold for the three months ended in Dec. 2023 was ₹25,331 Mil. Its Revenue for the three months ended in Dec. 2023 was ₹48,506 Mil.

Apollo Hospitals Enterprise's COGS to Revenue for the three months ended in Dec. 2023 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Apollo Hospitals Enterprise's Gross Margin % for the three months ended in Dec. 2023 was 47.78%.

Apollo Hospitals Enterprise COGS-to-Revenue Historical Data

The historical data trend for Apollo Hospitals Enterprise's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollo Hospitals Enterprise COGS-to-Revenue Chart

Apollo Hospitals Enterprise Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.54

0.52

Apollo Hospitals Enterprise Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.52	0.54	0.51	0.51	0.52

Apollo Hospitals Enterprise COGS-to-Revenue Calculation

Apollo Hospitals Enterprise's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	85743	/	164448
	=	0.52

Apollo Hospitals Enterprise's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	25331	/	48506
	=	0.52

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Apollo Hospitals Enterprise's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	25331 / 48506
	=	47.78 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Apollo Hospitals Enterprise COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Apollo Hospitals Enterprise's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

508869:India

Address

No. 8-17 Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600 006

Website

https://www.apollohospitals.com

Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. The firm receives the most proportion of revenue from its core healthcare business. The firm's standalone pharmacy segment contributes the second largest proportion of revenue.

Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Headlines

No Headlines